Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mobisante reels in $4.2M to market its ultrasound mobile app
FierceMedicalDevice
Monday, June 10, 2013 - 12:50pm
tags:
Mobisante, ultrasound, technology, mobile, devices
CryoLife receives CE Mark for HeRo Graft system
Yahoo/TheFlyOnTheWall
Monday, June 10, 2013 - 12:45pm
tags:
Cryolife, CE Mark, graft
BIOLASE Adds Two New Independent Directors to Its Board
Yahoo/MarketWired
Monday, June 10, 2013 - 12:45pm
tags:
BIOLASE IMAGING, Management, devices
MiMedx Announces Publication Of The Results From A Randomized Controlled Trial Of Its Advanced Wound Care Allograft, EpiFix®
Yahoo/PRNewswire
Monday, June 10, 2013 - 12:44pm
tags:
MiMedx, clinical trials, EpiFix, devices
Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Seeking Alpha
Monday, June 10, 2013 - 12:23pm
tags:
immunotherapy, NewLink Genetics, Roche, Genentech, Bristol-Myers Squibb, Merck, HyperAcute Lung, HyperAcute Pancreas
Discovery Labs Responds to FDA Request for Clarification of Recently Submitted SURFAXIN® (lucinactant) Updated Product Specifications
CP Wire
Monday, June 10, 2013 - 11:36am
tags:
Discovery Labs, FDA, Surfaxin, respiratory distress syndrome
Did You Know The Glaxo US HQ Is Really A Sublet 10-By-10 Foot Office?
Pharmalot
Monday, June 10, 2013 - 11:30am
tags:
GSK
FDA rejects Aveo kidney cancer drug, asks for additional trial
Reuters
Monday, June 10, 2013 - 11:20am
tags:
FDA, kidney cancer, Aveo Oncology, tivozanib
Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
Seeking Alpha
Monday, June 10, 2013 - 11:00am
tags:
ASCO, Infinity Pharmaceuticals, Gilead, IPI-145
Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?
Motley Fool
Monday, June 10, 2013 - 10:56am
tags:
Celgene, Abraxane, pancreatic cancer, Novartis, Pfizer
Sanofi announces FDA approved sBLA for licensure of influenza vaccine
Yahoo/Fly on the Wall
Monday, June 10, 2013 - 10:37am
tags:
FDA, Sanofi, vaccines, Sanofi Pasteur, flu vaccines, Fluzone Quadrivalent
CTSO: Tiny Med-Tech With Huge Potential
Yahoo/Zacks
Monday, June 10, 2013 - 10:34am
tags:
CytoSorbents, CytoSorbent
Sanofi MS drug nears green light after pass-the-parcel marathon
Reuters
Monday, June 10, 2013 - 10:33am
tags:
Sanofi, MS, multiple sclerosis, Lemtrada, Europe
Xenon licenses antisense drug SEN701 from Isis Pharmaceuticals
Yahoo/Fly on the Wall
Monday, June 10, 2013 - 10:16am
tags:
Xenon, antisense, SEN701, Isis Pharmaceuticals
FDA asks for more safety data on Dynavax's hepatitis B vaccine
Reuters
Monday, June 10, 2013 - 10:15am
tags:
FDA, hepatitis B, Dynavax, vaccines, Heplisav
ASCO Stocks That Should Sizzle in the Future
Motley Fool
Monday, June 10, 2013 - 10:12am
tags:
ASCO, Merck, Clovis Oncology, Bristol-Myers Squibb
AstraZeneca to Pay Up to $1.15 Billion for Pearl
Bloomberg
Monday, June 10, 2013 - 6:01am
tags:
M&A, Pearl Therapeutics, AstraZeneca
Shire’s New CEO Adds Sales Staff, Damps Takeover Talk
Bloomberg
Monday, June 10, 2013 - 6:00am
tags:
Pharma CEOs, Shire, hirings, Flemming Ornskov
Patent attorney frets that Supreme Court gene-patenting case will end badly for drug companies
Philadelphia Inquirer, PA
Monday, June 10, 2013 - 5:58am
tags:
Supreme Court, gene patents, Myriad Genetics
Arena's Belviq Discounts And Impacts On Revenue
Seeking Alpha
Monday, June 10, 2013 - 5:06am
tags:
Belviq, Arena Pharmaceuticals, Eisai, drug discounts

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.